601066:SSECSC Financial Co., Ltd. Class A Analysis
Data as of 2026-06-22 - not real-time
CN¥27.39
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The 20‑day SMA sits above the 50‑day SMA, while the price is testing the identified resistance near the 27.4 level, suggesting a potential breakout if momentum sustains. The MACD line remains above its signal, delivering a bullish signal, but the RSI hovers in the high‑60s, edging toward overbought territory.
Fundamental backdrop: Revenue has surged by over 60% year‑over‑year and operating margins are robust, yet the balance sheet is heavily leveraged with a debt‑to‑equity ratio approaching 300%. Cash reserves are ample, but the high debt load and modest ROE temper enthusiasm. The dividend yield sits around 1.3% with a payout ratio under 25%, indicating room for continuation, though sustainability is questionable given leverage. Overall, the stock appears undervalued relative to its DCF fair value, but the combination of valuation upside and elevated risk factors calls for a measured approach.
Fundamental backdrop: Revenue has surged by over 60% year‑over‑year and operating margins are robust, yet the balance sheet is heavily leveraged with a debt‑to‑equity ratio approaching 300%. Cash reserves are ample, but the high debt load and modest ROE temper enthusiasm. The dividend yield sits around 1.3% with a payout ratio under 25%, indicating room for continuation, though sustainability is questionable given leverage. Overall, the stock appears undervalued relative to its DCF fair value, but the combination of valuation upside and elevated risk factors calls for a measured approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover
- RSI approaching overbought levels
- Price near resistance with stable volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant revenue growth
- DCF valuation suggests substantial upside
- Attractive dividend yield relative to peers
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High leverage and regulatory exposure
- Sustainable cash generation but modest ROE
- Potential for dividend continuation if debt is managed
Key Metrics & Analysis
Financial Health
Revenue Growth61.40%
Profit Margin43.50%
P/E Ratio20.6
ROE9.71%
ROA1.63%
Debt/Equity290.77
P/B Ratio2.5
Op. Cash FlowCN¥93.1B
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI68.4
SupportCN¥22.10
ResistanceCN¥27.39
MA 20CN¥24.84
MA 50CN¥23.25
MA 200CN¥24.79
MACDBullish
VolumeStable
Fear & Greed Index90.14
Valuation
Fair ValueCN¥312.57
GradeUndervalued
TypeBlend
Dividend Yield1.33%
Risk Assessment
Beta0.42
Volatility47.08%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.